dpp 4 inhibitors and glp 1 GLP-1-RA DPP-4 in the management of type 2 diabetes DPP-4 inhibitors in the treatment

David Williams, president and CEO of Southside Medical Center, a Federally Qualified Health Center (FQHC)

The company says it is planning to initiate a Phase III development program with amycretin for adults with overweight or obesity during the first quarter of 2026

They are looking for red flags: commercial quantities, controlled substances, unpackaged medications, and people who seem evasive about what they are carrying

Acne (especially jawline, chin, lower-face) Spironolactone went from off-label option to evidence-based first-line for adult female acne in 2023 with the SAFA trial a UK multicenter, double-blind, placebo-controlled RCT of 410 women published in The BMJ and Health Technology Assessment